{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-109139","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.183776+00:00","generated_at":"2026-05-17T12:29:54.356992+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HCW Biologics amends $20M equity line to allow intraday share sales to Square Gate Capital","bullets":["First Amendment to $20M Equity Purchase Agreement with Square Gate Capital allows multiple intraday share purchases on same trading day.","Intraday Put Shares priced at 100% of lowest trade price during shortened valuation period after Transfer Agent confirms DWAC.","Company may submit additional put notices only after prior shares' DWAC confirmed; investor must accept within 30 minutes.","Total commitment remains $20M over 36 months; no other changes to original February 2025 terms."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-109139","json":"https://secwatch.observer/filing/0000950170-25-109139.json","markdown":"https://secwatch.observer/filing/0000950170-25-109139.md","text":"https://secwatch.observer/filing/0000950170-25-109139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025109139/0000950170-25-109139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025109139/hcwb-20250814.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T12:29:54.356992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}